lycopsamine N-oxide
CAS95462-15-0
lycopsamine N-oxide (CAS 95462-15-0, C15H25 N O6) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 95462-15-0
- Formula
- C15H25 N O6
- Mol. weight
- 315.37 g/mol
Chemical Specifications
Identifiers
| CAS number | 95462-15-0 |
|---|---|
| Product name | lycopsamine N-oxide |
| Synonyms | lycopsamine N-oxide; (1R,7aR)-2,3,5,7a-Tetrahydro-1α-hydroxy-7-[[(2S,3S)-2,3-dihydroxy-2-isopropylbutyryl]oxymethyl]-1H-pyrrolizine 4-oxide |
| Molecular formula | C15H25 N O6 |
| Molecular weight | 315.37 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Safety and transport
| Safety Statements | RIDADR 1544HazardClass 6.1(b)PackingGroup III |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of lycopsamine N-oxide?
The CAS Registry Number of lycopsamine N-oxide is 95462-15-0. lycopsamine N-oxide is also known as lycopsamine N-oxide; (1R,7aR)-2,3,5,7a-Tetrahydro-1α-hydroxy-7-[[(2S,3S)-2,3-dihydroxy-2-isopropylbutyryl]oxymethyl]-1H-pyrrolizine 4-oxide.
What is the molecular formula and molecular weight of lycopsamine N-oxide?
The molecular formula of lycopsamine N-oxide is C15H25 N O6, and its molecular weight is 315.37 g/mol.
How can I request a quotation for lycopsamine N-oxide?
Send an inquiry for lycopsamine N-oxide (CAS 95462-15-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for lycopsamine N-oxide
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.